AGIOS PHARMACEUTICALS, INC. — All Filings
1,000 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
144
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFM14A
DRS
EFFECT
FWP
POSASR
PREM14A
REGDEX
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000536 | Mar 26, 2026 | — |
| 4 | FORM 4 | 0001439222-26-000049 | Mar 9, 2026 | Mar 5, 2026 |
| 144 | — | 0001439222-26-000047 | Mar 5, 2026 | — |
| 4 | FORM 4 | 0001439222-26-000046 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | FORM 4 | 0001439222-26-000044 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0001439222-26-000042 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0001439222-26-000040 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0001439222-26-000038 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0001439222-26-000036 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0001439222-26-000034 | Mar 3, 2026 | Mar 1, 2026 |
| 4 | FORM 4 | 0001439222-26-000032 | Mar 3, 2026 | Mar 1, 2026 |
| 144 | — | 0001439222-26-000030 | Mar 2, 2026 | — |
| 144 | — | 0001439222-26-000029 | Mar 2, 2026 | — |
| 144 | — | 0001439222-26-000028 | Mar 2, 2026 | — |
| 144 | — | 0001439222-26-000027 | Mar 2, 2026 | — |
| 144 | — | 0001439222-26-000026 | Mar 2, 2026 | — |
| SCHEDULE 13G | — | 0001172661-26-001266 | Feb 17, 2026 | — |
| S-3ASR | S-3ASR | 0001193125-26-048780 | Feb 12, 2026 | — |
| 10-K | 10-K | 0001439222-26-000025 | Feb 12, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001439222-26-000023 | Feb 12, 2026 | — |
| SCHEDULE 13G/A | — | 0000908834-26-000066 | Feb 9, 2026 | — |
| 8-K | 8-K | 0001439222-26-000018 | Jan 12, 2026 | — |
| 4 | FORM 4 | 0001439222-26-000013 | Jan 7, 2026 | Jan 5, 2026 |
| 144 | — | 0001439222-26-000011 | Jan 5, 2026 | — |
| 4 | FORM 4 | 0001439222-26-000010 | Jan 2, 2026 | Dec 30, 2025 |
| 4 | FORM 4 | 0001439222-26-000008 | Jan 2, 2026 | Dec 30, 2025 |
| 4 | FORM 4 | 0001439222-26-000006 | Jan 2, 2026 | Dec 30, 2025 |
| 4 | FORM 4 | 0001439222-26-000004 | Jan 2, 2026 | Dec 30, 2025 |
| 4 | FORM 4 | 0001439222-26-000002 | Jan 2, 2026 | Dec 30, 2025 |
| 144 | — | 0001439222-25-000126 | Dec 30, 2025 | — |
| 144 | — | 0001439222-25-000125 | Dec 30, 2025 | — |
| 144 | — | 0001439222-25-000124 | Dec 30, 2025 | — |
| 144 | — | 0001439222-25-000122 | Dec 30, 2025 | — |
| 144 | — | 0001439222-25-000121 | Dec 30, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-118951 | Dec 5, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-112633 | Nov 14, 2025 | — |
| 4 | FORM 4 | 0001439222-25-000120 | Nov 14, 2025 | Nov 12, 2025 |
| 4 | FORM 4 | 0001439222-25-000118 | Nov 13, 2025 | Nov 11, 2025 |
| 144 | — | 0001950047-25-008736 | Nov 12, 2025 | — |
| 4 | FORM 4 | 0001881190-25-000004 | Nov 3, 2025 | Oct 30, 2025 |
| 144 | — | 0001950047-25-008305 | Oct 30, 2025 | — |
| 10-Q | 10-Q | 0001439222-25-000116 | Oct 30, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001439222-25-000114 | Oct 30, 2025 | — |
| 4 | FORM 4 | 0001439222-25-000111 | Oct 29, 2025 | Oct 27, 2025 |
| 144 | — | 0001950047-25-008210 | Oct 27, 2025 | — |
| 4 | FORM 4 | 0001439222-25-000108 | Oct 10, 2025 | Oct 8, 2025 |
| 144 | — | 0001950047-25-007829 | Oct 8, 2025 | — |
| 4 | FORM 4 | 0001439222-25-000106 | Oct 2, 2025 | Sep 30, 2025 |
| 4 | FORM 4 | 0001439222-25-000104 | Sep 30, 2025 | Sep 26, 2025 |
| 144 | — | 0001950047-25-007588 | Sep 30, 2025 | — |